Orthocell Ltd has released a press release.
CelGro Nerve Regeneration Results in Quadriplegic Patients
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Orthocell
- Successful CelGro Tendon Regeneration Trial
- CelGro Study Validates High Quality Nerve Repair
- CelGro Accelerates Dental Implant Treatments
- Orthocell announces successful capital raising
- First Patients Complete Nerve Regeneration Trial
Later from Orthocell
- Placement and Share Purchase Plan
- SPP Offer Document and Terms And Conditions
- US Nerve Repair Study Design Meets FDA Requirements
- Successful CelGro US Bone Repair Study
- CelGro US 510(k) Submission Completed
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell